Session Chair Profile
M.D., Senior Director, Head of Translational Genetics, Regeneron Genetics Center
Frederick Dewey received his AB in Chemistry and Physics from Harvard University, and MD, with concentration in cardiovascular and pulmonary sciences, from Stanford University. He received clinical training in internal medicine and cardiovascular medicine, and research training in human genetics at Stanford Hospital and Clinics. He joined the Regeneron Genetics Center, a wholly-owned subsidiary of Regeneron Pharmaceuticals, in 2014 and is currently Senior Director and Head of the Translational Genetics group, which uses large scale sequencing to identify and validate therapeutic targets.
Session Synopsis: Technology and cost revolutions enable large-scale genomics that now has the potential for accelerated and improved drug discovery and development supported by human genetics. Validated large-scale human genetics applications in drug development include indication discovery, target discovery, and pharmacogenetics-based biomarkers.